ALTITUDE LIFE SCIENCE VENTURES — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Generate Biomedicinesgeneratebiomedicines.comin𝕏NASDAQ: GENBNov 2021 · $370M
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.
AI & Machine LearningBiotechDeep TechSomerville, US
Gevorg Grigoryan(Co-Founder & Chief Technology Officer)in
Co-investorsFlagship PioneeringARCH Venture PartnersMarch Capital PartnersAlaska Permanent Fund CorporationNVenturesT. Rowe Price
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.